ARS Pharmaceuticals, Inc
SPRY
$4.18-1.18%
End of day · as of Oct 12, 2026, 11:00 PM ET
Mkt cap
$983.10M
EV/Sales
12.3
P/E ratio
N/A
FY2025 Revenue
$84.28M
EPS (TTM)
$-2.18
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-203.25%
Beta
N/A
Div yield
N/A
Sector
Healthcare
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported SPRY revenue for 2025-12-31 was $84.3M. Net income was -$171.3M. Revenue was down 5.5% from 2024-12-31 to 2025-12-31. SPRY currently screens at market cap $983.1M.
Use this SPRY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SPRY income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company in the Healthcare sector.
Latest cached ARS Pharmaceuticals, Inc (SPRY) revenue for Dec 31, 2025 was $84.3M. Net income was -$171.3M. Statements: https://lician.com/financials/spry
ARS Pharmaceuticals, Inc (SPRY) market capitalization is $983.1M on the latest cached snapshot.
ARS Pharmaceuticals, Inc (SPRY) cached previous close $4.23; day range $4.18 – $4.21; volume 1,272,983. Session quote: https://lician.com/quote/spry
ARS Pharmaceuticals, Inc (SPRY) latest cached earnings event is "SPRY earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SPRY filing is 8-K · Jul 17, 2026. Filings: https://lician.com/sec/spry